Sorano, Sumire
Chaponda, Enesia Banda
Mirandola, Massimo
Chikwanda, Ephraim
Mwewa, Vivian
Mulenga, Joyce M.
Chaponda, Mike
Ghilardi, Ludovica
Harding-Esch, Emma M.
Smith, Chris
Matsui, Mitsuaki
Chandramohan, Daniel
Ali, Mohamed Mahmoud
Blondeel, Karel
Unemo, Magnus
Toskin, Igor
Chico, R. Matthew
Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology, Japan (NA)
Article History
First Online: 31 January 2026
Declarations
:
: This study was approved by the WHO Ethics Review Committee (Protocol ID: ITD 8960), the London School of Hygiene & Tropical Medicine Ethics Committee (Protocol No. 26262), the Tropical Disease Research Centre Ethics Committee (IRB Registration: 00002911), recently renamed as Zambia’s National Health Research and Training Institute, and the Zambian National Health Research Authority (NHRA000002/01/06/2022). Written informed consent from prospective participants were obtained.
: Not applicable.
: Some authors are current or former staff members of the World Health Organization. The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the views, decisions or policies of the World Health Organization.
: This article has been published as part of BMC Infectious Diseases Volume 24 Supplement 1, 2024: Point-of-care Testing for Sexually Transmitted Infections: results of an independent multi-country clinic-based and clinic-utility evaluation of STI diagnostics (PRoSPeRo project). The full contents of the supplement are available online at .
: The authors declare no competing interests.